Philip J. Mofle, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-236-8100 |
Dr. Philip Kramer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-236-8100 |
Gwen D Martin, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-236-8100 |
William Krause, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 W Stout St, Rice Lake, WI 54868 Phone: 715-234-1515 |
News Archive
BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an investigational, oral, selective, potent second generation inhibitor of B-RAF, making it a targeted therapeutic candidate to potentially treat and bring benefit to patients with cancers that harbor BRAF mutations and/or aberrations in the RAS-MAPK (mitogen-activated protein kinase) pathway.
W. L. Gore & Associates today announced that it has received European CE Mark approval for the 25 cm GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface. The new 25 cm GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface is the longest length stent-graft available, designed to cover more of the lesion in the Superficial Femoral Artery potentially reducing the need for multiple devices.
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Micronics, Inc., a development-stage company, today announced that the Department of Defense has awarded the company an Applied Research and Technology Development Award under the U.S. Army Medical Research and Materiel Command's Polytrauma and Blast Injury project for advancement of its PanNAT system for point-of-care molecular diagnosis of infectious pathogens.
› Verified 6 days ago